Statistical inference for extended or shortened phase II studies based on Simon’s two-stage designs
نویسندگان
چکیده
BACKGROUND Simon's two-stage designs are popular choices for conducting phase II clinical trials, especially in the oncology trials to reduce the number of patients placed on ineffective experimental therapies. Recently Koyama and Chen (2008) discussed how to conduct proper inference for such studies because they found that inference procedures used with Simon's designs almost always ignore the actual sampling plan used. In particular, they proposed an inference method for studies when the actual second stage sample sizes differ from planned ones. METHODS We consider an alternative inference method based on likelihood ratio. In particular, we order permissible sample paths under Simon's two-stage designs using their corresponding conditional likelihood. In this way, we can calculate p-values using the common definition: the probability of obtaining a test statistic value at least as extreme as that observed under the null hypothesis. RESULTS In addition to providing inference for a couple of scenarios where Koyama and Chen's method can be difficult to apply, the resulting estimate based on our method appears to have certain advantage in terms of inference properties in many numerical simulations. It generally led to smaller biases and narrower confidence intervals while maintaining similar coverages. We also illustrated the two methods in a real data setting. CONCLUSIONS Inference procedures used with Simon's designs almost always ignore the actual sampling plan. Reported P-values, point estimates and confidence intervals for the response rate are not usually adjusted for the design's adaptiveness. Proper statistical inference procedures should be used.
منابع مشابه
188-2007: Using SAS® to Determine Sample Sizes for Traditional Two-Stage and Adaptive Two-Stage Phase II Cancer Clinical Trial Designs
In a Phase II clinical trial, the primary objective is to determine the efficaciousness of a drug, such that decisions to proceed with further studies and development of the drug are warranted. To detect a measurable effect in an investigation product, a two-stage design is often used, whereby an interim look at the data may result in the decision to terminate the trial early, or proceed with t...
متن کاملFull title: A likelihood-based approach to early stopping in single arm phase II cancer clinical trials Short title: Likelihood-based early stopping design in single arm phase II studies
In single arm phase II trials (in cancer research in particular), Simon’s twostage design has become most commonly used due to its simplicity, its ability to allow early stopping for futility, and preservation of type I and type II errors. As an alternative, likelihood-based approaches which allow frequent looks at the data and are similar to the Bayesian adaptive designs, whereby there is not ...
متن کاملBayesian two-stage designs for phase II clinical trials.
Many different statistical designs have been used in phase II clinical trials. The majority of these are based on frequentist statistical approaches. Bayesian methods provide a good alternative to frequentist approaches as they allow for the incorporation of relevant prior information and the presentation of the trial results in a manner which, some feel, is more intuitive and helpful. In this ...
متن کاملA discussion of an issue relating to sample sizes of exact phase II trial designs
A’Hern’s and Jung’s single stage designs are phase II trial designs based on dichotomous outcomes. They are used in the single arm and randomised settings respectively. Decision rules at the end of the study are based on a required number of either treatment successes or extra successes on the treatment arm. They are exact designs in that the power and alpha can be calculated directly using bin...
متن کاملA Hybrid Geometric Phase II/III Clinical Trial Design based on Treatment Failure Time and Toxicity.
The problem of comparing several experimental treatments to a standard arises frequently in medical research. Various multi-stage randomized phase II/III designs have been proposed that select one or more promising experimental treatments and compare them to the standard while controlling overall Type I and Type II error rates. This paper addresses phase II/III settings where the joint goals ar...
متن کامل